Stockreport

Kazia's Paxalisib Shows Positive Overall Survival Signal in Phase II Glioblastoma Study

Kazia Therapeutics Limited - American Depositary Shares  (KZIA) 
US:NASDAQ Investor Relations: kaziatherapeutics.com